Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

McMaster University

$25,000.00

Pre-treatment of plant extracts for enhancing recovery and purification of high-value bio-therapeutics

EF 2017-18

Résumé
Bio-therapeutics such as monoclonal antibodies which are widely used for treating life-threatening ailments arecurrently manufactured by mammalian cell culture. Large-scale production using mammalian cell culture istechnically challenging and expensive. Bio-pharming, i.e. expression of therapeutic proteins in plant is a novel,scalable, safe, economical, environment -friendly and promising alternative to mammalian cell culture.PlantForm Corporation is an Ontario based bio-pharming company with an established track record inmanufacturing tobacco based bio-therapeutics. The company recognises that feedstock pre-treatment beforeproduct purification could significantly affect the efficiency of the purification process. Such pre-treatment willtarget the removal of impurities such as RUBISCO and pigments present in tobacco extract using novelmembrane technology developed in the applicant's research group. Removing these key impurities throughpre-treatment step is expected to increase the overall purification efficiency and contribute towards increasedproduct purity and recovery, and lowering of manufacturing cost.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
520500-2017
Name nom
Ghosh, Raja
Department département
Chemical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
1
Nb partie
1
Application title
Pre-treatment of plant extracts for enhancing recovery and purification of high-value bio-therapeutics
Keyword
NSERC
Application summary
Bio-therapeutics such as monoclonal antibodies which are widely used for treating life-threatening ailments arecurrently manufactured by mammalian cell culture. Large-scale production using mammalian cell culture istechnically challenging and expensive. Bio-pharming, i.e. expression of therapeutic proteins in plant is a novel,scalable, safe, economical, environment -friendly and promising alternative to mammalian cell culture.PlantForm Corporation is an Ontario based bio-pharming company with an established track record inmanufacturing tobacco based bio-therapeutics. The company recognises that feedstock pre-treatment beforeproduct purification could significantly affect the efficiency of the purification process. Such pre-treatment willtarget the removal of impurities such as RUBISCO and pigments present in tobacco extract using novelmembrane technology developed in the applicant's research group. Removing these key impurities throughpre-treatment step is expected to increase the overall purification efficiency and contribute towards increasedproduct purity and recovery, and lowering of manufacturing cost.